News Alert

Influential Senator Extends 340B Inquiry to Community Health Centers

Sen. Bill Cassidy
Sen. Bill Cassidy (R-La.) sent letters to two community health centers that asked for detailed financial information on their 340B program revenue.
The top Republican on an influential Senate committee today asked two community health centers to submit detailed financial information on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Medicare to Continue ASP Plus 6% for 340B Drugs in 2024

CMS
CMS will continue its 2023 policy to pay for 340B products at the statutory default rate.
Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Finalizes 340B Lump Sum Payment, Retains Offsetting Cuts Starting in 2026

CMS headquarters
CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.
Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

GSK headquarters
Drugmaker GSK has loosened its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.
GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

HHS signage and building
A coming final rule would implement HRSA's administrative dispute resolution process to handle 340B program disputes between providers and drug manufacturers.
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novo Nordisk Files Suit to Block $100,000 Arkansas Fine for 340B Contract Pharmacy Violations

Novo Nordisk logo on building
The trial for Novo Nordisk's suit against Arkansas' 340B contract pharmacy law was scheduled for November 2024.
Danish drug giant Novo Nordisk filed suit Thursday to stop a proposed $100,000 fine from Arkansas over alleged violations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees

Bristol Myers Squibb
Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Ranking GOP Senator on Key Committee Opens Investigation into 340B Hospital Revenue

Bill Cassidy
Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.
The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

House Subcommittee Clashes Over 340B Role in Drug Shortages

Rep. Cathy McMorris Rodgers
Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.
A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report